Apop Biosciences

Powering cell stress detection

Apop Biosciences Pty Ltd (Apop) is an Australian biotechnology company established in October 2016 by founding director and medical researcher Assoc/Prof Peter Wookey, following decades of research into the role of the calcitonin receptor as a marker of disease. Dr Wookey’s research has been published in peer reviewed journals and presented at multiple scientific meetings.

 Apop’s catchy name was inspired by the major form of Programmed Cell Death (PCD),  apoptosis.

 

Research Reagents

Apop has launched CalRexin®:pHrodo™ Red, a first in class imaging reagent for real-time autophagy detection, enhancing our differentiated product offering to researchers and industry seeking better tools to detect and monitor cell stress processes. Apop’s proprietary antibody:fluorophore conjugates reveal novel pathways of autophagy programmed cell death in live cells and provide insights into these complex mechanisms previously unseen. 

 

Develop Therapeutics

Apop is developing CalRexin® into a powerful delivery vehicle for therapeutics (as antibody-toxin and antibody-drug conjugates) to treat refractory tumours.

 

Develop Imaging Agents

Apop is developing novel CalRexin® conjugates as diagnostic tools for real time imaging of PCD in patients.

https://www.apopbiosciences.com/

Show Product